Results

Total Results: 1,650 records

Showing results for "factor".

401. Rotator-Cuff-Tear-Surveillance-140925 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear-surveillance-140925.pdf
     February 01, 2014 - considered this CER conclusion still valid; one expert mentioned ‘fatty infiltration’ as a prognostic factor

402. Disposition of Comments for Efficacy and Safety of Screening for Postpartum Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
     May 01, 2013 - We have clarified that our purpose in reviewing the risk factor literature was primarily in the context … Question two needs to include factor: current antepartum depression (APD) or antepartum depressive … (risk factor or exposure, screening test, treatment, etc.) … quantifying these risks requires three specific estimates—the relative risk, the prevalence of the risk factor … The authors rightly point to the differences in the US and European health care systems as a factor

403. ADHD-Update-protocol-160818 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-update_research-protocol.pdf
     August 18, 2016 - stratified by sex, ADHD presentation, comorbidity (e.g., anxiety, depression), and specific risk factor … and 13-17 years, with findings stratified by sex, ADHD presentation, comorbidity, and specific risk factor

404. Diabetes-Behavior-Programs Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_research-protocol.pdf
     June 05, 2014 - • A factor was added to Key Questions 3 and 5, namely the “degree of tailoring based on needs assessment … accessibility was removed as an outcome although some aspects of this will be incorporated into the factor … advice or information) that is intended to increase adherence to medication for hyperglycemia or risk factor

405. Comparative Effectiveness of Coronary Bypass Surgery and Percutaneous Coronary Interventions for Multivessel Disease: A Pooled Analysis of Individual Patient Data from Ten Randomized Trials (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
     February 01, 2010 - the number of diseased coronary vessels, despite observational data strongly suggesting that this factor … variation in clinical effectiveness, since the extent of coronary disease is the strongest clinical factor

406. Methods Guide for Medical Test Reviews Chapter 12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
     July 01, 2012 - An essential factor to consider in a review is what followup times are especially informative to patients … Selective reporting biases in cancer prognostic factor studies.

407. Wheeled Mobility (Wheelchair) Service Delivery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-service_technical-brief.pdf
     January 01, 2012 - Given that inadequate training is a potential factor in predicting equipment abandonment, training for

408. Opioid Treatments for Chronic Pain Research Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
     December 19, 2018 - Opioid Treatments for Chronic Pain Research Protocol Evidence-based Practice Center Systematic Review Protocol Project Title: Opioid Treatments for Chronic Pain I. Background and Objectives for the Systematic Review Chronic pain, often defined as pain lasting longer than 3 to 6 months, or past the time of …

409. GRADING THE STRENGTH OF A BODY OF EVIDENCE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-strength_methods.pdf
     July 01, 2009 - GRADING THE STRENGTH OF A BODY OF EVIDENCE Methods Guide for Comparative Effectiveness Reviews ____________________________________________________________________________ Grading the Strength of a Body of Evidence When Comparing Medical Interventions Comparative Effectiveness Reviews are syst…

410. Traumatic Brain Injury and Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury-surveillance-160902.pdf
     January 30, 2014 - Attention"deficit"hyperactivity"disorder"as"a"risk"factor" for"concussions"in"NCAA"divisionKI"athletes … Factor"analysis"of"persistent" postconcussive"symptoms"within"a"military"sample"with"blast"exposure. … $ depression,$but$length$of$education$and$ current$work$status$combined$were$a$ significant$risk$factor … 11):1101"1111.$ $ $ OBJECTIVE:$Traumatic$brain$injury$(TBI)$is$increasingly$recognized$as$a$risk$factor … depression,$but$ length$of$education$and$ current$work$status$ combined$were$a$ significant$risk$factor

411. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/study-design-considerations-chapter-2.pptx
     January 01, 2013 - Slide 1 Study Design Considerations for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Study Design Considerations for Observational Comparative Effectiveness Research This slide set is based on a user guide titled Developing a Protoco…

412. Nonpharmacological Versus Pharmacological Treatment for Patients With Major Depressive Disorder: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_clinician.pdf
     September 01, 2016 - Nonpharmacological Versus Pharmacological Treatment for Patients With Major Depressive Disorder: Current State of the Evidence Nonpharmacological Versus Pharmacological Treatment for Patients With Major Depressive Disorder: Current State of the Evidence Focus of This Summary This is a summary of a systematic revie…

413. Comparative Effectiveness Research Review Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_disposition-comments.pdf
     February 13, 2012 - Affiliation Section Comment Response Peer Reviewer #3 Introduction Should there be mention of the factor … The findings of our report should be only one factor that is considered when deciding upon the best … The findings of our report should be only one factor that is considered when deciding upon the best

414. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
     September 01, 2020 - Therapies for Clinically Localized Prostate Cancer: Evidence Summary Comparative Effectiveness Review Number 230 Therapies for Clinically Localized Prostate Cancer Evidence Summary Main Points • In men with clinically localized prostate cancer (CLPC) detected clinically rather than by prostate-speci…

415. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Although apremilast appears to have a somewhat better tolerability profile than tumor necrosis factor

416. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_executive.pdf
     December 01, 2011 - tests require varying skills, equipment, and time to carry out, and heterogeneity is a significant factor … Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated

417. Hepatitis-C-Treatment-Adherence Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_executive.pdf
     September 22, 2011 - cirrhosis.15 Interventions for improving adherence can be categorized according to the primary risk factor

418. Prostate-Cancer-Therapies-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_executive.pdf
     December 01, 2014 - 1 Therapies for Clinically Localized Prostate Cancer: Update of a 2008 Systematic Review Executive Summary Background Prostate cancer is the most common nondermatologic cancer in men.1,2 The American Cancer Society has estimated that 241,740 men were expected to receive a diagnosis of prostate cancer in 2012, …

419. S123 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
     October 01, 2007 - If Z (an instrumental variable or “instrument”) represents a measured factor within W that is assumed

420. PKU Surveillance Assessment_CER 56_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
     January 15, 2013 - PKU Surveillance Assessment_CER 56_Low CER #56: Adjuvant Treatment for Phenylketonuria (PKU) Original release date: February 2012 Surveillance Report: January 2013 Key Findings: • All conclusions for KQ1-7 are still considered valid • No new significant safety concerns were identified. • Sever…